semaglutide injections and drinking alcohol Active ingredient in Ozempic, Wegovy shows early promise for treating use disorder among those with obesity: Study Semaglutide and Alcohol: What You

Novo Nordisk said in an email to CNN that it has been in ongoing dialogue with the FDA regarding the manufacturing and supply of Wegovy and Ozempic, and the company has remained confident in its supply since the shortage ended

Additionally, expanding indications beyond diabetes, such as weight management and cardiovascular risk reduction, are propelling market demand

Clinical assessment before restarting is advisable if you have had a prolonged interruption, particularly if this was due to side effects, illness, or surgery

Related read: Metabolic Adaptation: Why Your Weight Loss May Plateau

Semaglutide Pharmacokinetics and Dosing - National Institutes of Health : Detailed pharmacokinetic analysis of semaglutide including half-life, steady-state concentrations, and dose-response relationships that inform titration protocols

March 13, 2026: FDA Sends Warning Letter to Novo Nordisk The FDA has sent a warning letter to the maker of Ozempic and Wegovy over a potential failure to report side effects connected to these drugs